SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹87,693 Cr |
| Mar2024 | ₹81,396 Cr |
| Mar2023 | ₹77,225 Cr |
| Mar2022 | ₹66,958 Cr |
| Mar2021 | ₹64,110 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87,693 Cr | 7.74 | |
| Mar2024 | ₹81,396 Cr | 5.40 | |
| Mar2023 | ₹77,225 Cr | 15.33 | |
| Mar2022 | ₹66,958 Cr | 4.44 | |
| Mar2021 | ₹64,110 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,692.5 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹85,533.2 Cr | -0.9% | -5.8% | -18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% |
-1.3% |
-3.5% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses